ArticleCureus2025
Systemic Sarcoidosis Presenting With Hypercalcemia, Acute Kidney Injury, and Diffuse Lymphadenopathy: Unlocking Pandora's Box.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Marked Parathyroid Hormone (PTH)-Independent Hypercalcemia Revealing Sarcoidosis Mimicking Malignancy: A Case Report.Cureus · 2026Article
- Hydroxychloroquine's diverse targets: a new frontier in precision medicine.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcoidosis is a rare granulomatous disease with complex pathogenesis, nonspecific manifestations, and systemic sequelae leading to difficulties in differential diagnosis and increased potential for misdiagnosis. Renal involvement consists of an uncommon and underreported condition, especially in the absence of other extra-renal manifestations. Herein, we describe the case of a 58-year-old Caucasian female who presented with acute kidney injury alongside persistent hypercalcemia, diffuse lymphadenopathy, and B symptoms, namely, unintentional weight loss, fever, and fatigue. The laboratory findings revealed elevated creatinine and calcium levels, suppressed intact parathyroid hormone (iPTH) and increased calcitriol and angiotensin-converting enzyme (ACE) levels, raising suspicion of sarcoidosis. Renal biopsy revealed the presence of non-necrotizing granulomas, a pattern compatible with the diagnosis of sarcoidosis granulomatous interstitial nephritis (sGIN). Combined therapy with corticosteroids and hydroxychloroquine was initiated, and the patient's follow-up showed significant improvement in kidney function without relapses, highlighting the importance of early disease recognition and intervention. This case study unveils the diagnostic odyssey of the clinician to establish the diagnosis of sarcoidosis and prompts them to include such a diagnosis in their differential diagnosis algorithm in patients presenting with acute kidney injury, diffuse lymphadenopathy, and non-PTH-mediated hypercalcemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.